Clinical trial results show new Penn technology could be the key to fighting brain cancer
Financed in part by Kite Pharma, the study of a new cell therapy technique developed at Penn yielded positive early results in brain cancer patients.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: John George Source Type: news
More News: Brain | Brain Cancers | Cancer | Cancer & Oncology | Clinical Trials | Health Management | Neurology | Pharmaceuticals | Study